HPV vaccine : can we afford to hesitate?
Loading...
Date
Authors
Richter, Karin Louise
Dreyer, Greta
Lindeque, B. Gerhard
Botha, M.H.
Journal Title
Journal ISSN
Volume Title
Publisher
Health and Medical Publishing Group
Abstract
Cervical cancer, caused by human papillomavirus
(HPV) infection, is highly prevalent in sub-Saharan Africa. The
estimated annual incidence of cervical cancer is 35/100 000 women,
with 22.5/100 000 associated deaths. This is in stark contrast to the
6.6/100 000 cases and 2.7/100 000 deaths reported in developed
countries such as the USA, where HPV vaccination has been available
since 2006.
Description
Keywords
Cervical canver, HPV vaccine, Human papillomavirus (HPV), Vaccination
Sustainable Development Goals
Citation
Richter, KL, Dreyer, G, Lindeque, BG & Botha, MH 2014, 'HPV vaccine : can we afford to hesitate?', South African Medical Journal, vol. 104, no. 8, pp. 522-523.